SENSEX NIFTY
Ranbaxy Laboratories Quarterly Results, Ranbaxy Laboratories Financial Statement & Accounts
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 22, 16:20
635.40
-5.2 (-0.81%)
VOLUME 95,179
LIVE
NSE
Aug 22, 16:20
636.45
-4.25 (-0.66%)
VOLUME 681,229
Download Annual Report PDF Format 2014 | 2011 | 2010

Quarterly Results of Ranbaxy Laboratories

------------------- in Rs. Cr. -------------------
Jun '14 Mar '14 Dec '13 Sep '13 Jun '13
Net Sales/Income from operations 2,116.98 1,224.59 1,327.64 1,381.84 1,395.10
Other Operating Income 61.65 27.43 38.93 43.99 43.79
Total Income From Operations 2,178.63 1,252.02 1,366.56 1,425.84 1,438.89
EXPENDITURE
Consumption of Raw Materials 280.73 394.87 432.75 427.49 401.61
Purchase of Traded Goods 184.27 224.77 219.36 184.24 163.59
Increase/Decrease in Stocks 102.74 3.29 -82.70 -70.65 14.15
Power & Fuel -- -- -- -- --
Employees Cost 254.74 226.27 271.91 267.67 263.07
Depreciation 65.65 49.98 45.85 94.41 44.65
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 429.76 440.48 591.29 718.97 747.24
P/L Before Other Inc. , Int., Excpt. Items & Tax 860.74 -87.64 -111.90 -196.28 -195.43
Other Income 25.76 636.50 20.60 44.35 31.04
P/L Before Int., Excpt. Items & Tax 886.50 548.86 -91.30 -151.93 -164.38
Interest 141.91 110.85 118.39 111.08 156.13
P/L Before Exceptional Items & Tax 744.59 438.02 -209.69 -263.01 -320.51
Exceptional Items 19.77 490.41 -186.28 -579.22 -288.30
P/L Before Tax 764.36 928.43 -395.96 -842.23 -608.81
Tax 9.24 30.57 -- -- --
P/L After Tax from Ordinary Activities 755.12 897.86 -395.96 -842.23 -608.81
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 755.12 897.86 -395.96 -842.23 -608.81
Equity Share Capital 211.78 211.66 211.55 211.57 211.55
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 17.83 21.22 -9.36 -19.92 -14.40
Diluted EPS 17.80 21.19 -9.36 -19.92 -14.40
EPS After Extra Ordinary
Basic EPS 17.83 21.22 -9.36 -19.92 -14.40
Diluted EPS 17.80 21.19 -9.36 -19.92 -14.40
Public Share Holding
No Of Shares (Crores) 14.49 14.88 14.80 14.28 14.57
Share Holding (%) 34.18 35.11 34.93 33.75 34.43
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) 26.87 26.87 26.87 26.87 26.87
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) 63.40 63.41 63.41 63.51 63.51
Notes Notes To The Accounts
Source : Dion Global Solutions Limited
Quick Links for ranbaxylaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.